Cuba approves the use of the Abdala anticovid vaccine in children from 2 to 11 years old

Cuba approves the use of the Abdala anticovid vaccine in children from 2 to 11 years old

This drug, developed by the Center for Genetic Engineering and Biotechnology (CIGB), has an efficacy of 92.28% in its complete scheme and, as in adults, comprises three doses in total and an interval of 14 days between each application.

“The tribute that the Cuban National Assembly gave to Cuban scientists and doctors yesterday was not fortuitous. We owe them a lot, “added the president.

The island’s health authorities confirmed that more than one million Cuban children and adolescents between the ages of two and 18 have already received two doses of Soberana 02, as part of the immunization campaign in pediatric ages, according to the Sputnik news agency.

To date, 87.7% of the island’s population received at least one dose of one of the Cuban inoculants Soberana 02, Soberana Plus, and Abdala, while 63.6% already have the full schedule.

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts